Benefits
Bone mineral density support
Population studies consistently show positive associations between dietary silicon intake and bone mineral density in pre- and postmenopausal women and men. A 2-year RCT with ch-OSA® showed significant improvements in bone collagen markers (CICP) and a trend toward improved bone mineral density — suggesting silicon supports the collagen matrix component of bone rather than just mineral density.
Collagen synthesis stimulation
Orthosilicic acid stimulates collagen type 1 synthesis in osteoblasts, fibroblasts, and chondrocytes — the structural protein scaffold upon which bone mineral is deposited. Silicon has been proposed to support prolyl hydroxylase (an enzyme involved in collagen maturation) and matrix stability, offering a possible mechanistic explanation for its bone and connective tissue effects.
Skin, hair, and nail quality improvement
ch-OSA® RCTs in women with photoaged skin showed significant improvements in skin microrelief, skin elasticity, and hair tensile strength after 20 weeks — attributed to increased dermal collagen synthesis. Silicon's role in cross-linking structural proteins (collagen, elastin, glycosaminoglycans) explains its cosmetic skin and hair applications.
Aluminum binding in the digestive tract
Orthosilicic acid forms stable, non-absorbable aluminosilicate complexes in the GI tract and may reduce aluminum absorption from diet and water. Some observational studies have looked at associations between silicon-rich drinking water and cognitive aging, but the underlying aluminum-neurotoxicity hypothesis remains scientifically contested and unproven. Silicon supplements are not intended to treat or prevent any neurological disease.
Mechanism of action
Prolyl hydroxylase activation and collagen crosslinking
Orthosilicic acid appears to stabilize prolyl hydroxylase — the enzyme that hydroxylates proline residues in procollagen, enabling hydroxyproline formation essential for collagen triple helix stability and crosslinking. Silicon may also interact directly with the hydroxyl groups of collagen and glycosaminoglycans, stabilizing the extracellular matrix structure.
Osteoblast collagen gene expression upregulation
OSA at physiological concentrations stimulates osteoblasts to increase expression of collagen type 1 alpha-1 (COL1A1) and osteocalcin genes, and activates osteoblast differentiation markers. This direct osteoblast stimulation explains silicon's effects on the organic (protein) component of bone matrix — complementary to calcium's effects on the inorganic mineral component.
Aluminosilicate formation and aluminum binding
Silicon and aluminum form insoluble aluminosilicate complexes at physiological pH. In the GI tract, dietary silicon reduces aluminum absorption by forming these complexes before intestinal absorption can occur. Some research suggests silicon may modestly increase urinary aluminum excretion. Any downstream health significance of this is unproven, and the link between aluminum and neurological disease remains contested.
Clinical trials
Randomized, double-blind, placebo-controlled trial of ch-OSA® (10 mg/day bioavailable silicon) vs. placebo combined with calcium + vitamin D3 in 136 osteopenic women for 12 months.
136 osteopenic women. 12-month intervention.
ch-OSA® significantly increased a marker of type I collagen (bone) formation versus placebo plus calcium/vitamin D3. A favorable but non-significant femoral-neck BMD trend in a post-hoc subgroup. Supports silicon as bone collagen-targeting supplement complementary to calcium.
Randomized, double-blind, placebo-controlled trial of ch-OSA® (10 mg/day silicon) in 50 women with photoaged skin for 20 weeks.
50 women with photoaged facial skin. 20-week cosmetic study.
ch-OSA® significantly improved skin microrelief score, skin roughness, and skin elasticity vs. placebo. Hair tensile strength significantly improved. Nail brittleness reduced. Confirms silicon's structural role in connective tissue cosmetic outcomes.